true

BD Accuspray™ nasal spray system

BD tools for vaccine combination product developers

accuspray nasal spray banner
Loading
Overview

The BD AccusprayTM Nasal Spray System is a monodose or bidose* nasal prefillable delivery system. If given the option between intranasal or injectable vaccination 88.3% adults prefer intranasal delivery.1 Easy to vaccinate2, BD Accuspray™ Nasal Spray System is suitable for high quantities and cold chain when space is critical: small size barrel contributes to reduced storage space. The system is based on BD HypakTM for Vaccines Glass Prefillable Syringe for easy implementation on filling lines.

*if the dose divider is used
Features and Benefits

BD Accuspray™  Nasal Spray System Features

  • Disposable system for nasal administration of vaccines
  • Non-reusable, single use nasal sprayer for monodose or bidose* administration
  • BD AccusprayTM complies with ISO 10993-13; USP <381>4, <660>5,6, <661>7; Ph Eur 3.1.88, 3.2.16, 3.2.94
 
*if the dose divider is used

BD Accuspray™  Nasal Spray System Benefits

  • Intranasal delivery is preferred 88.3% by adults in the study if given the option between intranasal or injectable vaccination1
  • Easy to vaccinate2
  • Suitable for high quantities and cold chain9 when space is critical: small size barrel contributes to reduce storage space
  • Based on BD HypakTM for Vaccines Glass Prefillable Syringe for easy implementation on filling lines:
        o   Product can be filled on standard PFS filling line worldwide
        o   Leverage internal/external filling infrastructure
  • Products are provided Sterile, Clean and ready to Fill* (BD SCFTM)
  • Broad range of value added services*
        o   Functional tests in c-GMP compliant labs
        o    Regulatory expertise in Drug Device Combination Product (DDCP) submissions

* Barrel and spray nozzle are delivered assembled, to be further assembled with stopper and plunger rod.

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Reference
  1. Sheldon et al. (2013) Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study. Influenza and Other Respiratory Viruses 7(6), 1142–1150
  2. Dubé et al., April 2015, Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada, Human Vaccines & Immunotherapeutics. Survey conducted to explore knowledge, attitudes and practices of 314 vaccine providers regarding use of LAIV. During the vaccination campaign, 71% of responded having used LAIV delivered with Accuspray. Almost all of these respondents indicated that it was easy to vaccinate children with the vaccine delivered with Accuspray (57% strongly agreed)
  3. Materials Of Concern And Safety Information, 442.MOCASI.28, valid from April 2021
  4. USP <381> “Elastomeric Components in Injectable Pharmaceutical Product Packaging/Delivery Systems” (Dec. 2020) and EP 3.2.9 “Rubber Closures for Containers for Aqueous Parental Preparations, for powders and for freeze-dried powders” (Jul 2018) compliance statement for W7028/ 55, STMT-QE20213696, Sept. 2021
  5. USP <660> “Containers-Glass” (May 2015), STMT-20161598, April 2021
  6. Hydrolytic resistance conformity of glass canes to the new version of EP 3.2.1.“Glass containers for pharmaceutical use”, STMT-QE20191153, April 2019
  7. USP <661> “Plastic packaging systems and their materials of construction”, STMT-QE20213531, Sept. 2021
  8. Ph Eur 3.1.8 "Silicone oil used as a lubricant“, STMT-QE20170709, Dec 2020
  9. BD internal references, EF20202208, EF20202618, EF20203052,TP20211855, TR20213724, EF20213171 BD-01-SR-01, BD-02-SR-01, BD-03-SR-01, BD Medical – Pharmaceutical Systems Le Pont de Claix, France
  10. BD sales analysis [internal analysis]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2021.
Expertise & Availability

Our Expertise in the BD AccusprayTM Nasal Spray System

  • More than than 150 million BD AccusprayTM units10 sold since 2003

 

Availability

  • Samples available on demand
  • Commercial availability to be evaluated against requirements

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Reference
  1. Sheldon et al. (2013) Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study. Influenza and Other Respiratory Viruses 7(6), 1142–1150
  2. Dubé et al., April 2015, Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada, Human Vaccines & Immunotherapeutics. Survey conducted to explore knowledge, attitudes and practices of 314 vaccine providers regarding use of LAIV. During the vaccination campaign, 71% of responded having used LAIV delivered with Accuspray. Almost all of these respondents indicated that it was easy to vaccinate children with the vaccine delivered with Accuspray (57% strongly agreed)
  3. Materials Of Concern And Safety Information, 442.MOCASI.28, valid from April 2021
  4. USP <381> “Elastomeric Components in Injectable Pharmaceutical Product Packaging/Delivery Systems” (Dec. 2020) and EP 3.2.9 “Rubber Closures for Containers for Aqueous Parental Preparations, for powders and for freeze-dried powders” (Jul 2018) compliance statement for W7028/ 55, STMT-QE20213696, Sept. 2021
  5. USP <660> “Containers-Glass” (May 2015), STMT-20161598, April 2021
  6. Hydrolytic resistance conformity of glass canes to the new version of EP 3.2.1.“Glass containers for pharmaceutical use”, STMT-QE20191153, April 2019
  7. USP <661> “Plastic packaging systems and their materials of construction”, STMT-QE20213531, Sept. 2021
  8. Ph Eur 3.1.8 "Silicone oil used as a lubricant“, STMT-QE20170709, Dec 2020
  9. BD internal references, EF20202208, EF20202618, EF20203052,TP20211855, TR20213724, EF20213171 BD-01-SR-01, BD-02-SR-01, BD-03-SR-01, BD Medical – Pharmaceutical Systems Le Pont de Claix, France
  10. BD sales analysis [internal analysis]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2021.

Related Product Families

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Resources

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
true
BD Accuspray™ Nasal Spray System BD BD Accuspray™ nasal spray system

BD Accuspray™  Nasal Spray System Features

,
  • Disposable system for nasal administration of vaccines
  • Non-reusable, single use nasal sprayer for monodose or bidose* administration
  • BD AccusprayTM complies with ISO 10993-13; USP <381>4, <660>5,6, <661>7; Ph Eur 3.1.88, 3.2.16, 3.2.94
 
*if the dose divider is used
,

BD Accuspray™  Nasal Spray System Benefits

,
  • Intranasal delivery is preferred 88.3% by adults in the study if given the option between intranasal or injectable vaccination1
  • Easy to vaccinate2
  • Suitable for high quantities and cold chain9 when space is critical: small size barrel contributes to reduce storage space
  • Based on BD HypakTM for Vaccines Glass Prefillable Syringe for easy implementation on filling lines:
        o   Product can be filled on standard PFS filling line worldwide
        o   Leverage internal/external filling infrastructure
  • Products are provided Sterile, Clean and ready to Fill* (BD SCFTM)
  • Broad range of value added services*
        o   Functional tests in c-GMP compliant labs
        o    Regulatory expertise in Drug Device Combination Product (DDCP) submissions

* Barrel and spray nozzle are delivered assembled, to be further assembled with stopper and plunger rod.

/content/dam/bd-assets/bd-com/en-us/logos/bd/header-bd-logo.svg

BD tools for vaccine combination product developers

299906 Potato dextrose agar, screw cap 299502 BD Fluid Thioglycollate Medium (FTM), Bottle, 200 ml 299436 R2A agar, screw cap 299417 Fluid thioglycollate medium, septum screw cap 299416 BD Trypticase soy broth, septum screw cap 299113 BD Trypticase soy broth, septum screw cap 299112 Fluid thioglycollate medium, septum screw cap 299111 Fluid A, 500 mL, septum screw cap 299110 Fluid D, 500 mL, septum screw cap 299108 Fluid thioglycollate medium, serum 299107 BD Trypticase soy broth, serum 299102 Standard methods agar, septum screw cap 299099 BD Trypticase™ soy agar, screw cap 299098 Sabouraud detrose agar with chloramphenicol, screw cap 299094 Standard methods agar, screw cap 292610 BD Tryptic Soy Agar (TSA) 2X, Bottle, 100 ml 292391 Fluid A, 100 mL, septum screw cap 292333 BD Fluid Thioglycollate Medium (FTM) with Beef Extract, Bottle, 100 ml 290831 Fluid D, serum (0.1% peptic digest of animal tissue and polysorbate 80) 290821 Fluid A, serum (0.1% peptic digest of animal tissue) 290721 TAT broth, wide mouth 290701 Lactose broth, wide mouth 290662 Fluid D, septum screw cap (0.1% peptic digest of animal tissue and polysorbate 80) 290652 Fluid A, septum screw cap (0.1% peptic digest of animal tissue) 257731 BD IC-XT Pack Sanitizer Neutralizing Agar (30 ml) 257631 BD BactoTM Peptone Water, Bottle, 400 ml 257602 BD Fluid A, Double Wrap Bottle, 300 ml 257578 BD Lactose Broth, Syrup Bottle, 100ml 257577 BD Lactose Broth, Syrup Bottle, 100ml (Double Strength) 257563 BD Modified Letheen Broth with 5% Tween, Bottle, 500 ml 257536 BD Fluid D, Crimp Cap Bottle, 300 ml 257488 Tryptic soy broth, wide mouth bottle, 90 mL 257486 Tryptic soy broth, wide mouth bottle, 100 mL 257485 Fluid thioglycollate medium, wide mouth bottle, 100 mL 257458 BD Sterile Water, Bottle, 500ml (not for injection) 257411 BD Tryptic Soy Broth (TSB), Bottle, 200ml 257385 Phosphate buffer (pH 7.2), stock solution, 100 mL 257371 BD Tryptic Soy Broth (TSB), Bottle, 100ml (EtO) 257370 BD Fluid Thioglycollate Medium (FTM), Bottle, 100 ml (EtO) 257336 BD R2A Agar, Bottle, 100ml 257327 BD Modified Letheen Broth, Bottle, 500ml 257276 BD Tryptic Soy Broth (TSB), Syrup Bottle, 100ml 257266 BD Sterile Water, Double Wrap Bottle, 400ml (not for injection) 257265 BD Tryptic Soy Broth (TSB), Double Wrap Bottle, 100ml 257261 BD Sabouraud Glucose Agar, Bottle, 400ml 257236 BD Sterility Handeling Kit - Tools 257235 BD Sterility Handeling Kit - Media 257222 BD Fluid A, Double Wrap Bottle, 650 ml 257211 BD Tryptic Soy Broth (TSB), Bottle, 50ml (EtO) 257205 BD Tryptic Soy Broth (TSB) with 1% Polysorbate 80, Bottle, 100ml 257161 BD Tryptic Soy Broth (TSB), Bottle, 50ml 257159 BD Tryptic Soy Broth (TSB), Bottle, 100ml 257140 BD Casein Hammarsten 10%, Bottle, 500ml 257114 BD D/E (Dey/Engley) Neutralizing Broth, Bottle, 100ml 257087 Buffered sodium chloride peptone solution (pH 7.0), 500 mL 257086 Buffered sodium chloride peptone solution (pH 7.0), 100 mL 257078 BD Peptone Water 0.1%, Bottle, 500 ml 256665 BD Tryptic Soy Agar (TSA), Bottle, 100 ml 215289 BD Fluid Thioglycollate Medium (FTM) with Lecithin and Polysorbate 80, Screw Cap Bottle with Septum, 500 ml 215193 Sabouraud dextrose broth, 100 mL 215192 Reinforced clostridial medium, 100 mL 215148 BD Sterile Pack R2A (18 ml)
nasal vaccine delivery, prefillable nasal spray, needle-free vaccine device, cold-chain nasal system, intranasal drug administration, patient-friendly spray system, monodose nasal injector, vaccine spray device, needle-free immunization, spray system for mass vaccination